In a population-based series of 806 patients with relapsing remitting onset multiple sclerosis from the London Ontario database and with an extended 28 years follow-up, we revaluated the predictive value of relapses.
We also observed that the WT1 median values of nonrelapsing patients were lower than the median values of relapsing patients, but in our case we were not able to replicate the results of previous studies in which the mean/median WT1 values [ 11, 12] or other cut-offs [ 5, 7, 8, 10, 13– 19] were used to stratify patients at different risks of relapse.
Furthermore, this study identified a small set of variables that help predict subsequent relapse in the usual treatment of schizophrenia, demonstrating the predictive value of prior relapse as a robust marker, along with prior medication nonadherence, younger age at illness onset, having health insurance, and poorer level of functioning.
We identified patients having WT1 ratios exceeding these thresholds and then determined the sensitivity, specificity, negative predictive value, and positive predictive value of subsequent relapse.
The predictive value of early relapse number and first inter-attack interval for long-term disability outcomes has been addressed (Confavreux et al., 1980, 2000, 2003; Weinshenker et al., 1989 b ; Kantarci et al., 1998).
Users have to specify a time-to-event variable ('DaysToDFS' in this case, which indicates the time to the earliest event or time to the last evaluation for patients without any events), a status indicator ('CompRisk', which has a value of 1 for relapse, 2 for non-relapse mortality and 0 for no event), and grouping variables, if required ('Source' in this case).
Only patients with at least two PSA values since suspicion of relapse were included.
As a novelty, we observe a strong prognostic value for relapse-free survival of the BRAF mutation status in the MSS/left-colon tumors.
The positive value of the DID estimate represents the smoking cessation percentage, while the negative value may indicate that of relapse of smoking.
Let μ(X) be the expected value of the number of relapses; N X), the total observation period; λ(X), the constant relapse rate of MS; X, the covariate vector; and β, the parameter vector to be estimated.
